Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2011-11-30
Original market date: See footnote 1
1987-12-31
Product name:
HEPALEAN 10,000 USP
DIN:
00740497
Product Monograph/Veterinary Labelling:
Date:
2009-08-10
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SCHERING-PLOUGH CANADA INC
3535 Route Trans Canada Highway
Pointe-Claire
Quebec
Canada
H9R 1B4
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous , Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
20:12.04.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
B01AB01 HEPARIN
Active ingredient group (AIG) number:See footnote5
0104596002
| Active ingredient(s) | Strength |
|---|---|
| HEPARIN SODIUM | 10000 UNIT / ML |